Lifecore Biomedical, Inc. DE
LFCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001005286
No open-market purchases or sales by Lifecore Biomedical, Inc. DE insiders were filed in the last 90 days; 98 institutions reported holding it in 13F filings for Q2 2026, worth $133.3M in total; no superinvestor holds it.
Holders of 5% or more of LFCR
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Lifecore Biomedical, Inc. DE, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Greenhaven Road Investment Management, L.P. | 13G/A | 9.80%3.62M shares | +2.00 ppfrom 7.80% | Feb 14, 20252 filings | Feb 14, 2025 | SEC |
| 22NW Fund, LP | 13D/A | 7.49%2.98M shares | −3.61 ppfrom 11.10% | Dec 26, 20242 filings | May 29, 2025 | SEC |
| LW Capital Management, LLC | 13G | 5.20%1.58M shares | New | Feb 14, 20241 filing | Feb 14, 2024 | SEC |
| BlackRock, Inc. | 13G | 5.10%1.90M shares | +0.20 ppfrom 4.90% | Jul 17, 20253 filings | Jan 21, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
9 Schedule 13D and 13G filings on Lifecore Biomedical, Inc. DE, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jan 21, 202612:30 PM ET | BlackRock, Inc. | 13G | 5.10%1.90M shares | +0.20 ppfrom 4.90% | Dec 31, 2025 | SEC |
| Oct 17, 20256:41 PM ET | BlackRock, Inc. | 13G/A | 4.90%1.83M shares | −0.10 ppfrom 5.00%Below 5% | Sep 30, 2025 | SEC |
| Jul 17, 20258:12 PM ET | BlackRock, Inc. | 13G | 5.00%1.87M shares | New | Jun 30, 2025 | SEC |
| May 29, 20259:56 PM ET | 22NW Fund, LPand 6 others | 13D/A | 7.49%2.98M shares | −3.61 ppfrom 11.10% | May 27, 2025 | SEC |
| Feb 14, 20254:44 PM ET | Greenhaven Road Investment Management, L.P.and 4 others | 13G/A | 9.80%3.62M shares | +2.00 ppfrom 7.80% | Dec 31, 2024 | SEC |
| Feb 14, 20254:44 PM ET | Greenhaven Road Investment Management, L.P.and 4 others | 13G/A | 7.80%2.37M shares | – | Dec 31, 2023 | SEC |
| Feb 5, 20253:24 PM ET | David Capital Partners, LLCand 1 other | 13G/A | 4.87%1.80M shares | –Below 5% | Dec 31, 2024 | SEC |
| Dec 26, 20241:20 PM ET | 22NW Fund, LPand 6 others | 13D/A | 11.10%4.37M shares | – | Dec 23, 2024 | SEC |
| Feb 14, 20243:39 PM ET | LW Capital Management, LLCand 2 others | 13G | 5.20%1.58M shares | New | Dec 31, 2023 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Lifecore Biomedical, Inc. DE shares.
No Form 144 notices for Lifecore Biomedical, Inc. DE are on file.